Sterix Limited
Records under this name other than patents Sterix Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,846,737 | Compound Formerly held Lapsed on the fee record Ended Sep 30, 2026 · High confidence | Lapsed on the fee record | Ended Sep 30, 2026 | High confidence |
| US RE42,132 | Antitumoral D-homoestra-1,3,5(10)-trien-3-yl 2-substituted sulfamates Term ended Term ended Feb 19, 2024 · From the USPTO record | Term ended | Term ended Feb 19, 2024 | From the USPTO record |
| US 8,148,415 | Sulfamic acid ester compounds useful in the inhibition of steroid sulphatase activity and aromatase activity Lapsed on the fee record Ended Apr 3, 2020 · From the USPTO record | Lapsed on the fee record | Ended Apr 3, 2020 | From the USPTO record |
| US 8,119,627 | Heterocyclic Compounds as Inhibitors of 17BETA-HSD3 Formerly held Lapsed on the fee record Ended Feb 21, 2020 · High confidence | Lapsed on the fee record | Ended Feb 21, 2020 | High confidence |
| US 8,093,279 | Compound Lapsed on the fee record Ended Jan 10, 2020 · From the USPTO record | Lapsed on the fee record | Ended Jan 10, 2020 | From the USPTO record |
| US 8,030,296 | Oestrogen-17-sulphamates as inhibitors of steroid sulphatase Lapsed on the fee record Ended Oct 4, 2019 · From the USPTO record | Lapsed on the fee record | Ended Oct 4, 2019 | From the USPTO record |
| US 8,022,224 | 1,2,4-triazol-1-yl bisphenyl derivatives for use in the treatment of endocrine-dependent tumors Lapsed on the fee record Ended Sep 20, 2019 · From the USPTO record | Lapsed on the fee record | Ended Sep 20, 2019 | From the USPTO record |
| US 7,119,081 | Oestrogen-17-sulphamates as inhibitors of steroid sulphatase Lapsed on the fee record Ended Oct 10, 2018 · From the USPTO record | Lapsed on the fee record | Ended Oct 10, 2018 | From the USPTO record |
| US 6,083,978 | Compounds with a sulfamate group Term ended Term ended Sep 2, 2018 · From the USPTO record | Term ended | Term ended Sep 2, 2018 | From the USPTO record |
| US 7,098,218 | Steroidal compounds for inhibiting steroid sulphatase Formerly held Lapsed on the fee record Ended Aug 29, 2018 · From the USPTO record | Lapsed on the fee record | Ended Aug 29, 2018 | From the USPTO record |